| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Warrant transaction costs | 0 | 0 |
| Net cash provided by financing activities | 2,094 | 2,094 |
| Net change in cash and cash equivalents | 1,115 | 732 |
| Cash and cash equivalents at beginning of period | 2,594 | - |
| Cash and cash equivalents at end of period | 3,709 | - |
AVENUE THERAPEUTICS, INC. (ATXI)
AVENUE THERAPEUTICS, INC. (ATXI)